SCHEMBL7538176

SCHEMBL7538176

CCCCCCCC/C=C\CCCCCCCCN(CC)CCNC(=O)C(F)(F)F

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.55
FAAH O00519 4/20 0.48
CES1 P23141 2/20 0.48
EPHX2 P34913 6/20 0.43
ALDH1A1 P00352 2/20 0.43
PLA2G4B P0C869 1/20 0.43
MAPT P10636 1/20 0.43
PLA2G4A P47712 1/20 0.43
BLM P54132 1/20 0.43
MGLL Q99685 1/20 0.43
PLA2G4C Q9UP65 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CNR1 P21554 1/20 0.42
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7538172 0.95 EPHX1 (0.63) EPHX1FAAHCES1EPHX2ALDH1A1
SCHEMBL7543543 0.95 EPHX1 (0.63) EPHX1FAAHCES1EPHX2ALDH1A1
SCHEMBL7539129 0.92 EPHX1 (0.65) EPHX1FAAHCES1ALDH1A1MEN1
SCHEMBL7542360 0.92 EPHX1 (0.65) EPHX1FAAHCES1ALDH1A1MEN1
SCHEMBL7535887 0.87 EPHX1 (0.63) EPHX1FAAHCES1EPHX2ALDH1A1
SCHEMBL7542534 0.87 EPHX1 (0.63) EPHX1FAAHCES1EPHX2ALDH1A1
SCHEMBL7539126 0.86 EPHX1 (0.75) EPHX1ALDH1A1MEN1KMT2APOLB
SCHEMBL7535768 0.86 EPHX1 (0.75) EPHX1ALDH1A1MEN1KMT2APOLB
SCHEMBL7536111 0.86 EPHX1 (0.75) EPHX1ALDH1A1MEN1KMT2APOLB
SCHEMBL7542355 0.86 EPHX1 (0.75) EPHX1ALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200454-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE Novuspharma S.p.A. (IT) 2002-05-02 EP disclosed
WO-2001009149-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE NOVUSPHARMA S.P.A. (IT) 2001-02-08 WO disclosed